Bristol Myers Squibb Co. (BMY)
62.19
-0.13
(-0.21%)
USD |
NYSE |
Nov 13, 10:17
Bristol Myers Squibb Price to Book Value : 5.431 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 5.443 |
| November 11, 2026 | 5.494 |
| November 10, 2026 | 5.485 |
| November 09, 2026 | 5.427 |
| November 06, 2026 | 5.427 |
| November 05, 2026 | 5.514 |
| November 04, 2026 | 5.606 |
| November 03, 2026 | 5.390 |
| November 02, 2026 | 5.504 |
| October 30, 2026 | 5.457 |
| October 29, 2026 | 5.362 |
| October 28, 2026 | 5.290 |
| October 27, 2026 | 5.376 |
| October 26, 2026 | 5.381 |
| October 23, 2026 | 5.369 |
| October 22, 2026 | 5.502 |
| October 21, 2026 | 5.338 |
| October 20, 2026 | 5.387 |
| October 19, 2026 | 5.138 |
| October 16, 2026 | 5.218 |
| October 15, 2026 | 5.290 |
| October 14, 2026 | 5.177 |
| October 13, 2026 | 4.949 |
| October 12, 2026 | 5.029 |
| October 09, 2026 | 5.163 |
| Date | Value |
|---|---|
| October 08, 2026 | 5.203 |
| October 07, 2026 | 5.214 |
| October 06, 2026 | 5.204 |
| October 05, 2026 | 5.136 |
| October 02, 2026 | 5.341 |
| October 01, 2026 | 5.368 |
| September 30, 2026 | 5.450 |
| September 29, 2026 | 5.754 |
| September 28, 2026 | 5.847 |
| September 25, 2026 | 5.754 |
| September 24, 2026 | 5.630 |
| September 23, 2026 | 5.597 |
| September 22, 2026 | 5.698 |
| September 21, 2026 | 5.732 |
| September 18, 2026 | 5.772 |
| September 17, 2026 | 5.752 |
| September 16, 2026 | 5.822 |
| September 15, 2026 | 5.834 |
| September 14, 2026 | 5.868 |
| September 11, 2026 | 5.825 |
| September 10, 2026 | 5.835 |
| September 09, 2026 | 5.896 |
| September 08, 2026 | 5.922 |
| September 04, 2026 | 6.116 |
| September 03, 2026 | 6.233 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 8.424 |
| Eli Lilly & Co. | 33.25 |
| Merck & Co., Inc. | 8.011 |
| Pfizer Inc. | 1.843 |
| AstraZeneca PLC | 12.12 |
Price to Book Value Related Metrics
| PE Ratio | 13.78 |
| PS Ratio | 2.544 |
| PEG Ratio | 0.2631 |
| Price to Free Cash Flow | 13.71 |
| Price | 62.19 |
| Earnings Yield | 7.26% |
| Market Cap | 127.12B |
| PEGY Ratio | 0.2442 |
| Operating PE Ratio | 7.725 |
| Normalized PE Ratio | 9.741 |